In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD‐0332991) for treating canine mammary tumours
Author:
Affiliation:
1. Institute of Pharmacology and Toxicology, Unit of Clinical PharmacologyUniversity of Veterinary Medicine Vienna Austria
2. Institute of Pathology and Forensic Veterinary MedicineUniversity of Veterinary Medicine Vienna Austria
Publisher
Wiley
Subject
General Veterinary
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/vco.12514
Reference90 articles.
1. Population‐based incidence of mammary tumours in some dog breeds;Moe L;J Reprod Fertil Suppl,2001
2. Epidemiological study of mammary tumors in female dogs diagnosed during the period;Salas Y;PLoS One,2002
3. Canine Mammary Epithelial Neoplasms: Biologic Implications of Morphologic Characteristics Assessed in 232 Dogs
4. The retrospective analysis of mammary tumors in dogs;Ezerskyte A;Vet Med Zoot,2011
5. Histological Grading and Prognosis in Dogs with Mammary Carcinomas: Application of a Human Grading Method
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Canine Breast Carcinomas: Recent Advances in Diagnostic and Treatment Strategies;Advanced Therapeutics;2024-08-16
2. Mammary carcinoma: Comparative oncology between small animals and humans—New therapeutic tools;Reproduction in Domestic Animals;2023-07-12
3. The Carnitine Palmitoyltransferase 1A Inhibitor Teglicar Shows Promising Antitumour Activity against Canine Mammary Cancer Cells by Inducing Apoptosis;Pharmaceuticals;2023-07-10
4. Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-β, and CDK4 in canine urothelial carcinoma;Journal of Veterinary Diagnostic Investigation;2023-01-17
5. Decreased sensitivity of cyclin-dependent kinase 4/6 inhibitors, palbociclib and abemaciclib to canine lymphoma cells with high p16 protein expression and low retinoblastoma protein phosphorylation;Journal of Veterinary Medical Science;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3